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SUMMARY
1. To examine the role of prostaglandins in physiologically induced renin release,
we reduced renal artery pressure within the autoregulatory range in chronically
instrumented conscious dogs with aspirin, indomethacin or no pre-treatment.
2. In untreated dogs, reduction of renal artery pressure to 60 mmHg for 90 min
produced rises in plasma renin activity (+ 5-4+1I0 ng ml.-' hr-') and mean arterial
pressure (+ 17 + 2 mmHg) without significant effect on renal blood flow (n = 13).
3. Aspirin pre-treatment (2 x 25-40 mg kg-' orally) had no effect on the renin,
arterial pressure or renal blood flow responses to renal artery pressure reduction
(n = 7). In contrast, indomethacin pre-treatment (2 x 2-3 mg kg-' orally) signifi-
cantly lessened the increase in plasma renin activity during reduced renal artery
pressure (+2-0+03 ng ml.-' hr-, n = 11).
4. The relative effectiveness of aspirin and indomethacin in inhibiting prosta-
glandin production in the kidney was then tested in separate experiments by
measuring the renal blood flow responses to renal artery injections of arachidonate
(5-200 jug kg-'). In the doses used above, aspirin markedly attenuated the blood flow
response to arachidonate but indomethacin had almost no effect. Both aspirin and
indomethacin abolished the hypotensive effect of intravenous arachidonate (0-5 mg
kg-1).
5. These results tentatively suggest that indomethacin may not effectively inhibit
renal prostaglandin production in conscious dogs at the doses used in these experi-
ments. Thus the reduced renin release in response to lowered renal artery pressure in
indomethacin pre-treated dogs may have been due to another, non-prostaglandin
action of indomethacin.
6. The results from the aspirin pre-treated dogs suggest that prostaglandins are
not involved in the release of renin in response to reduced renal artery pressure in
conscious dogs.
INTRODUCTION
Arachidonic acid, the prostaglandin precursor, and various individual prosta-
glandins stimulate the release of renin from the kidney in vivo and in vitro (see Dunn
& Zambraski, 1980; Dunn & Hood, 1977 and Dusting, Moncada & Vane, 1979 for
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reviews of this literature). In addition, the prostaglandin synthase inhibitor
indomethacin has been reported to reduce the renin response to a number of stimuli,
particularly in anaesthetized animals and in vitro renal preparations (Dunn &
Zambraski, 1980; Dunn & Hood, 1977; Dusting et al. 1979). This and other evidence
has led to the suggestion thatprostaglandins may be the obligatory endogenous
mediators of renin release from the kidney (Dusting et al. 1979; Moncada & Vane,
1980), although Dunn & Zambraski (1980) note that there is conflicting evidence for
a role ofprostaglandins in some circumstances. Since there is evidence that
prostaglandin production may be augmented by surgical procedures in anaesthetized
animals (Terragno, Terragno & McGiff, 1977; Swain, Heyndrickx, Boettcher &
Vatner, 1975), we have examined the importance ofprostaglandins in physiologically
induced renin release in conscious, chronically instrumented dogs. We reduced renal
artery pressure within the autoregulatory range in conscious dogs and compared the
effects of two inhibitors of prostaglandin production (indomethacin and aspirin) on
the response.
METHODS
Preparation of dog8
Trained chronically instrumented dogs were prepared as previously described (Anderson,
Johnston & Korner, 1979; Anderson & Korner, 1980; Anderson, Korner, Angus & Johnston, 1981).
In brief, male mongrel dogs (average weight 24 kg) were trained to lie quietly on a low padded table
in a quiet laboratory. The dogs were then instrumented under halothane/nitrous oxide anaesthesia,
after initial induction with thiopentone. The left renal artery was exposed via a flank incision, and
an inflatable silastic cuff and a Doppler flowmeter were placed around the artery. A thin catheter(0-8 mm external diameter) was inserted into the renal artery distal to the cuff and two further
catheters were placed in the abdominal aorta. Another catheter was placed in the inferior vena cava.
The right kidney was removed through a right flank incision. In about one out of five dogs, double
renal arteries to the left kidney necessitated its removal and preparation of the right renal artery.
The catheters were exteriorized on the chest wall and protected by a canvas jacket. The dogs were
given pethidine at the end of the operation, and penicillin (250 mg day-') and streptomycin(250 mg day-') for 5 days. They had free access to water and were fed a diet of raw beef and biscuits
which gave them a daily Na* intake of about 60m-moles. At least 2 weeks were allowed between
surgery and the experiments. By this time, the dogs were thoroughly accustomed to the laboratory
by daily visits to the laboratory for catheter flushing.
Experiments
Reduction of renal artery pressure. All experiments were conducted with the dogs quietly
recumbent. After a 30 min control period, the silastic cuff around the renal artery was inflated to
lower distal pressure to 60 mmHg. This pressure was then maintained at 60 mmHg for 90 min by
frequent adjustments of the degree of cuff inflation. After 90 min the cuff was deflated and the
changes followed for another 30 min.
Prior to the experiment, the dogs were given indomethacin, aspirin or no drug. Indomethacin
was given at 2-3 mg kg-' orally in two doses 2 hr apart and aspirin was given at 25-40 mg kg-'
in two doses 3 hr apart. Renal artery stenosis was induced approximately 45 min after the second
doses of indomethacin or aspirin.
As far as possible each dog was studied three times; i.e. with indomethacin, aspirin and
no pre-treatment in random order. This was however not possible in all dogs due to technical
failures, usually rupture of the wall of the renal artery beneath the hard shells of the Doppler flow
probes between experiments. At least 10 days were allowed between experiments. All successfully
completed experiments have been included in the results (n = 11, 7 and 13 for indomethacin, aspirin
and no pre-treatment respectively), with separate analysis of the results from dogs in which paired
experiments were performed, comparing no pre-treatment with either indomethacin (n = 7) or
aspirin (n = 5) pre-treatments.
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Test of inhibition of renal prostaglandin synthesis. In a separate group of dogs the degree of
functional blockade ofprostaglandin synthesis in the kidney by indomethacin and aspirin was tested
by measuring the renal blood flow response to injections of the prostaglandin precursor,
arachidonate. Na+ arachidonate (Nuchex) was injected in bolus doses of 5-200 sg kg-' into the
renal artery. Indomethacin (n = 6) and aspirin (n = 7) were given at the doses used for the main
series of experiments described above. The effect of a third drug, phenylbutazone (10-12 mg kg-'
orally), on the renal blood flow response to arachidonate was also studied.
The arterial blood pressure response to intravenous Na+ arachidonate injections (0-5-1 mg kg-')
were also studied before and after indomethacin (n = 7) and aspirin (n = 5).
Measurements
Aortic and renal artery pressures were measured via the implanted catheters, using Statham
P23Dc transducers and a Devices recorder. Renal blood flow was measured in kHz Doppler shift
and converted to millilitres per minute using a calibration factor of 84 ml. min' kHz-'. We have
previously published details of the Doppler flowmetry technique (Anderson et al. 1979, 1981;
Anderson & Korner, 1980). Renal vascular resistance was calculated as distal renal artery pressure
ivided by renal blood flow. Plasma renin activity was measured by radioimmunoassay from
arterial blood sampled through one of the aortic catheters (Anderson et al. 1979). Plasma salicylate
concentrations were measured by the technique of Trinder (1957). Plasma indomethacin levels
were measured by high pressure liquid chromatography (Skellern & Salole, 1975).
Statistics
Responses to stenosis were compared by Student's t test of the difference between resting values
and average values after 60-90 min of renal artery pressure reduction and by analysis of variance,
with appropriate partitions of the 'between times' sums of squares to allow testing the significant
changes within groups and comparison of changes between groups. Regression lines were compared
by analysis of covariance.
RESULTS
Response to renal artery pressure reduction
Renal artery pressure was reduced to 60 mmHg by partial inflation of the cuff
around the renal artery, and then maintained at this pressure for 90 min. The volumes
of saline needed to inflate the cuff to achieve this pressure are given in Table 1. The
responses in the dogs pre-treated with aspirin or indomethacin were compared to
those in dogs with no pre-treatment. In all, thirteen dogs were studied without
pre-treatment, eleven dogs with indomethacin pre-treatment and seven dogs with
aspirin pre-treatment. The results from these dogs are shown in Fig. 1. Ofthese, paired
indomethacin and no pre-treatment experiments were performed in seven dogs and
paired experiments ofaspirin and no pre-treatment were performed in five dogs. These
results are given in Fig. 2A, B (respectively).
In dogs with no drug pre-treatment, reduction of distal renal artery pressure
produced a rapid rise in plasma renin activity which reached steady-state levels at
60 and 90 min (+ 5-4+1-0 ng ml.-' hr-' above control), (Fig. 1). Arterial blood
pressure also began to increase almost immediately and reached steady-state levels
which were 17 + 2 mmHg above resting levels (Fig. 1). Reduction of renal artery
pressure to 60 mmHg had no significant effect on renal blood flow, either initially
(1-6+ 85% above resting values) or after 60-90 min (4-6 + 8-4% below resting)
(Fig. 1).
In dogs with indomethacin pre-treatment, there was a smaller rise in plasma renin
activity in response to renal artery pressure reduction than in the untreated dogs
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(Figs. 1 and 2A). The average rise in plasma renin activity at 60 and 90 min was
2-0+03ngml.-1hr-t (n= 11) compared to 5-4+1±Ongnl.-1hr-' (n= 13) in
untreated dogs (P < 0-05 unpaired Student's t test, (Fig. 1). For the seven dogs with
paired experiments, the rises in plasma renin activity were 1D8+ 0-2 and 4-4+ 1-5 ng
ml.-' hr-1 with and without indomethacin pre-treatment respectively (P < 0-05),
TABLE 1. Renal artery pressure reduction
Cuff inflation volume (ml. saline)
Pre-treatment Initially After 30 min After 90 min
None 0'20 + 0-02 0-25 + 0-02 0-28 +003
Aspirin 0 19 + 003 0-25 +004 0-28 +0 04
Indomethacin 0-19+0X02 0-23+002 0X25+0*01
Degree of inflation of the cuff around the renal artery required to initially reduce distal pressure
to 60 mmHg and to maintain it at 60 mmHg for, 30 and 90 min.
No pre-treatment Indomethacin pretreatment Aspirin pre-treatment
A Renal artery stenosis B Renal artery stenosis C Renal artery stenosis
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Fig. 1. Responses to renal artery stenosis to reduce distal pressure to 60 mmHg for 90 mmn
(between vertical arrows). Conscious dogs were studied after no pre-treatment with
cyclo-oxygenase inhibitors, (A, it = 13) and after indomethacin pre-treatment (B, it = 11)
and aspirin pre-treatment (C, it =7). Blood pressures and renal blood flow are depicted
as means of values averaged over 5 mmn periods in each dog, ±5.E. of the mean. Plasma
renin activity is shown as means of samples taken at the times indicted + S.E. of the mean.
(Fig. 2A). Fig. 3 shows the rise in plasma renin activity in paired experiments in
individual dogs. The rise in arterial pressure was also less in indomethacin pre-treated
dogs (7X8 mmHg compared to 15-3 mmHg without indomethacin, 0 05 < P < 0'1, by
analysis of variance), (Fig. 2A). The renal blood flow response to renal artery pressure
reduction was not however altered by indomethacin (Fig. 2A).
In contrast to indomethacin, aspirin pre-treatment of these conscious dogs did
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Indomethacin versus No pre-treatment
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Fig. 2. Average effects of renal artery pressure reductions to 60 mmHg for 90 min. Values
between 60 and 90 min were averaged and expressed as change (A) from resting
values in each dog. The plotted bars represent the mean values (±S.x.D.) of seven dogs
which received indomethacin and no pre-treatment in separate paired experiments
(Fig. 2A), and five dogs which received aspirin and no pre-treatment in separate paired
experiments (Fig. 2B). (P < 0 05 denotes a significant difference between the response in
the dogs pre-treated with indomethacin or aspirin compared to that when the dogs were
untreated; where no P value is given, aspirin or indomethacin had no significant effect
on the response).
not affect the response to reduction of renal artery pressure to 60 mmHg (Figs. 1
and 2B). In the five dogs in which paired experiments were performed with aspirin
and no pre-treatment, plasma renin activity rose 3-9 + 0 7 and 4-8 + 2-1 ng ml-' hr-'
respectively, arterial pressure rose 15-9+ 4-5 and 13-3+ 3-0 mmHg respectively, and
renal blood flow fell 9+ 21 and 11 + 15% respectively (Fig. 2B). These are the changes
from control averaged from 60-90 min post-stenosis and there is no significant
difference between the responses in the two groups for any variable. This is also the
case if the results for all seven aspirin pre-treated and thirteen untreated dogs are
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compared (Fig. 1). Fig. 3 shows the rises in plasma renin activity in individual dogs;
in four out of five dogs the rise was greater after aspirin pre-treatment than without
pre-treatment.
Neither aspirin nor indomethacin significantly affected resting arterial pressure,
renal blood flow or plasma renin activity.
A B
10| \ N
C
None I ndo. None Aspirin
Pre-treatment
Fig. 3. Effects of 60-90 min reduction ofrenal artery pressure to 60 mmHgon plasma renin
activity. Values shown are the averages of arterial blood samples taken after 60 and 90 min
of renal artery pressure reduction, in individual dogs. Results show (A), the values in seven
dogs pre-treated with indomethacin (indo.) or with no pre-treatment in separate
experiments and (B), the values in five dogs pre-treated with aspirin or with no
pre-treatment in separate experiments (results in each dog joined by dotted line).
In indomethacin pre-treated dogs, plasma indomethacin concentrations were
3-1 + 0'6 jug ml.-' immediately prior to reduction ofrenal artery pressure to 60 mmHg
and -1 ±+02,ug ml.-' 90 min later. Plasma salicylate values were 97-7 + 7-6 and
90'8+ 7-9 jug ml.-' at these times in aspirin pre-treated dogs.
Arachidonate injections
Injections of arachidonate into the renal artery produced dose-related increases
in renal blood flow in the absence of aspirin or indomethacin (Fig. 4). Doses from
5jg kg-' to 200 jug kg-' increased renal blood flow without effects on systemic arterial
pressure. Doses of 400 jug kg-1 or greater tended to lower arterial pressure and were
therefore not used.
Aspirin markedly reduced the renal blood flow response to renal artery arachidonate
injections (Fig. 4A). For example, 50 j#g kg-' arachidonate increased renal blood flow
by 24+ 5% before aspirin and by only 8+ 2% after aspirin. In contrast, indomethacin
had virtually no effect on the magnitude of the renal blood flow response to
arachidonate (Fig. 4B). Analysis of covariance revealed that the slightly reduced
slope of the regression of flow on arachidonate dose after indomethacin was not
significant (Fig. 4B). The duration of the renal blood flow responses to arachidonate
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were also not altered by indomethacin. Phenylbutazone gave similar results to those
of aspirin, markedly reducing the renal blood flow response to arachidonate; e.g.
50 ,tg kg-' arachidonate increased renal blood flow by 271+7-1 % before and by
1 8 +± -0 % after phenylbutazone, and 100ug kg-' arachidonate increase flow by
39-0 + 8-5% before and 16-8 + 37 % after phenylbutazone (n = 4).
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Fig. 4. Effect of bolus injections of arachidonate into the renal artery on renal blood flow
(peak changes), before and after aspirin (top, n = 7) or indomethacin (lower, n = 6).
Histograms on the right of each graph show the average resting values before and after
aspirin or indomethacin treatment (not significantly different in either case).
Intravenous injections of arachidonate (0-5 mg kg-1) produced marked falls in
arterial pressure (Fig. 5), lasting 3-5 min. The peak reduction in arterial pressure
occurred 0-5-2 min after injection and was associated with tachycardia (+ 26+ 8 Hz).
Indomethacin and aspirin pre-treatment both completely abolished this response to
0 5 mg kg-' arachidonate i.v. (Fig. 5). Indomethacin also reduced the hypotensive
response to 1 mg kg-' arachidonate i.v., from 35.5 + 6-0 mmHg to 6-0 + 2-5 mmHg.
DISCUSSION
The results of this study do not support the claim that prostaglandins are
'obligatory endogenous mediators' of renin release from the kidney (Dusting et al.
1979; Moncada & Vane, 1979). Neither aspirin nor indomethacin completely blocked
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the rise in plasma renin levels in response to prolonged reduction of renal artery
pressure. In fact aspirin pre-treatment had no effect on the renin response to
reduced renal artery pressure. In contrast indomethacin did reduce, but not abolish,
the renin response to reduced renal artery pressure. However this effect of indome-
thacin may not have been due to its inhibition of prostaglandin production as
explained below.
A B
Resting Arachidonate
100 After indometacin
o L E 80
-
Before indomethaci
70
100_
90 e- After aspirin
E E 80
Ii i Before aspirin
60
*
Resting | Arachidonate
in
Fig. 5. The effect of intravenous bolus arachidonate (05 mg kg-) on mean arterial
pressure before and after indomethacin (top) or aspirin (bottom). The Figure shows average
resting values immediately prior to arachidonate injection (A, resting) and peak reduction
in pressure after arachidonate injection (B, arachidonate).
We decided to use two chemically dissimilar non-steroidal anti-inflammatory drugs
in this study because such drugs are known to have a diversity of activities on
biological mechanisms apart from inhibition of prostaglandin synthesis (Flower,
Moncada & Vane, 1980). We administered the drugs aspirin and indomethacin in
doses commonly used by other workers, but we also assessed the inhibitory effects
of the two drugs on prostaglandin synthesis. We did this by measuring the
cardiovascular effects of the prostaglandin precursor substance arachidonate, in-
jected into the renal artery or intravenously before and after aspirin and indo-
methacin. Arachidonate injected into the renal artery produced dose-related increases
in renal blood flow and intravenous arachidonate produced hypotension. Both aspirin
and indomethacin blocked the hypotensive response to intravenously injected
arachidonate, but only aspirin blocked the renal vasodilatatory response to intrarenal
arachidonate. That is, indomethacin did not block metabolism of arachidonate to
vasodilatory substances after intrarenal injections, but did block this metabolism
after intravenous injection. This suggests that indomethacin did not effectively
108
ASPIRIN, INDOMETHACIN AND RENAL PROSTAGLANDINS 109
inhibit prostaglandin production from arachidonate in the kidney, whereas aspirin
did, and that both drugs inhibited prostaglandin production elsewhere in the body.
A third drug, phenylbutazone, produced similar results to aspirin. Confirmation of
the results of this functional test, suggesting that indomethacin did not inhibit renal
prostaglandin synthase, will require more direct measurements of prostaglandin
production and the present results should therefore be interpreted cautiously. For
example, arachidonate is a substrate for other enzymes such as lipoxygenase. It is
therefore possible that a drug which inhibits cyclo-oxygenase might divert arachi-
donate metabolism into vasodilatory leukotrienes, although the results with aspirin
and phenylbutazone argue against this possibility. Another potential problem with
this functional assay is that indomethacin can inhibit the catabolism ofprostaglandins
as well as the synthesis at some doses (Pace-Asciak & Cole, 1975), but the duration
of effect of arachidonate on renal blood flow was not affected by indomethacin in the
present experiments. Furthermore, the effects of arachidonate metabolism on renal
blood flow, rather than on renin release, were assessed by this assay. On the other
hand, an advantage of this functional test of inhibition of renal prostaglandin
production is that it was performed in situ in the experimental setting used in the
main set of experiments. We have no explanation for the apparent failure of
indomethacin to inhibit renal prostaglandin produced in these unanaesthetized dogs.
However, the effectiveness of this hydrophobic drug depends on its concentration in
the particular target tissue and it may be noteworthy in this regard that very little
indomethacin is excreted in urine in dogs in contrast to other species (Hucker,
Zacchei, Cox, Brodie & Cantwell, 1966). Higher doses of indomethacin may be
required to inhibit renal prostaglandin production but the dose used here is commonly
employed and the blood levels of indomethacin achieved were high compared to those
reported for therapeutic use in man (e.g. Alvan, Orme, Bertilsson, Ekstrand &
Palmer, 1975; Watkins, Abbot, Hensby, Webster & Dollery, 1980). It is commonly
assumed that an effect of indomethacin is synonymous with an action of prosta-
glandins although it is rarely specifically tested whether indomethacin has inhibited
prostaglandin production. The results from our experiments do not constitute
conclusive proof that indomethacin failed to inhibit renal prostaglandin production,
but it would seem prudent not to necessarily equate an effect of indomethacin on the
kidney with a role for prostaglandins.
Indomethacin did reduce the amount of renin released in response to reduction of
renal artery pressure. This occurred in spite of the drug's apparent failure to inhibit
renal prostaglandin production and is in contrast to the effect of aspirin. This effect
of indomethacin may therefore be via another action of this drug. Indomethacin has
been reported to have several actions in the body apart from the inhibition of
prostaglandin production (Dunn & Zambraski, 1980), including, inhibition of phos-
phodiesterase (Newcombe, Thanassi & Ciosek, 1974), protein kinase (Kantor &
Hampton, 1978) and adenosine transport (Phillis & Wu, 1981).
The results from the experiments using aspirin argue against a role for prosta-
glandins in the release of renin during reduction of renal perfusion pressure within the
autoregulatory range. The dose of aspirin used achieved high plasma levels (cf. Data,
Chang & Nies, 1976), was shown to alter renal arachidonate metabolism in dogs in
this study, and was greater than that previously shown to inhibit renal prostaglandin
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synthase in vitro (Caterson, Duggin, Horvath, Mohandas & Tiller, 1978). Despite this,
pre-treatment of dogs with aspirin did not alter the renin response to reduction of
renal artery pressure to 60 mmHg for 90 min. This suggests either that prostaglandin
production was not stimulated by reduction of renal artery pressure within the
autoregulatory range in conscious dogs, or that prostaglandins were produced but
had no effect on renin release. The latter is unlikely because it is well proven that
exogenously applied prostaglandins or arachidonic acid stimulate renin release in vivo
and in vitro (e.g. Gerber, Keller & Nies, 1979; Seymour & Zehr, 1979; Weber, Larsson,
Anggard, Hamberg, Corey, Nicolaou & Samuelsson, 1976). Thus these aspirin results
suggest that prostaglandin production was not stimulated by reduction of renal
artery pressure within the autoregulatory range in conscious dogs and oppose the
hypothesis that prostaglandins necessarily mediate renin release (Dusting et al. 1979;
Moncada & Vane, 1979). Other investigators have also recently shown that renin
release may occur independently of prostaglandins in a variety of circumstances (e.g.
Dietz, Davis, DeForrest, Freeman, Echtenkamp & Seymour, 1981; Dietz, Davis,
Freeman, Echtenkamp & Villarreal, 1981; Seymour, Davis, Echtenkamp, Dietz &
Freeman, 1981). It has also recently been shown that prostaglandins do not
apparently mediate renin release during even severe reductions in renal blood flow
in conscious dogs (Anderson, 1982).
Greater renal vasoconstriction might have been expected in the aspirin pre-treated
dogs compared to untreated dogs in response to reduced renal artery pressure.
Angiotensin II can be shown to liberate arachidonic acid and increase renal
prostaglandin production in some in vitro kidney preparations and in anaesthetized
animals (Aiken & Vane, 1973; Needleman, Kauffman, Douglas, Johnston & Marshall,
1973, Schlondorff, Roczniak, Satriano, & Folkert, 1980; Zusman & Keiser, 1977) and
prostaglandins modify the renal blood flow response to infusions of angiotensin II
in conscious dogs (Swain et al. 1975). Thus as angiotensin II levels increased in parallel
with the increasing plasma renin levels during the 90 min period of reduced renal
artery pressure, renal vascular resistance might have been higher in the dogs with
inhibition of prostaglandin production and renal blood flow may have fallen more.
However, neither indomethacin nor aspirin altered the response of renal blood flow
or renal vascular resistance to reduction of renal artery pressure, in agreement with
previously published results (e.g. Anderson, Taher, Cronin, McDonald & Schrier,
1975; Bell, Sinclair & Parry, 1975).
In summary, prostaglandins were not apparently involved in the renin or renal
blood flow responses to reduced renal artery pressure in conscious dogs. This
conclusion is based on findings that aspirin was without effect during reduction of
renal artery pressure to 60 mmHg, despite its apparent inhibition of renal prosta-
glandin production. The results therefore suggest that prostaglandins may not be
obligatory mediators of the physiologically induced release of renin. The results also
tentatively suggest that indomethacin, in the doses used here, may not effectively
inhibit renal prostaglandin production in dogs but may inhibit renin release by
another mechanism.
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Preliminary poster presentations of parts of this work have been presented to symposia on
Prostaglandins and the Kidney, Stuttgart, 1980, and Arachidonic Acid Metabolites and the Kidney,
Rome, 1981.
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